Targeted Pediatric High-Grade Glioma Therapy

Abroad (travel likely)Recruiting

Conditions

High Grade Glioma · Diffuse Intrinsic Pontine Glioma · Anaplastic Astrocytoma · Glioblastoma · Glioblastoma Multiforme · Diffuse Midline Glioma, H3 K27M-Mutant · Metastatic Brain Tumor · WHO Grade III Glioma · WHO Grade IV Glioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Children's Hospital Colorado, Aurora, Colorado, United States
Contact: Study coordinator (Holly Lindsay, MD) · holly.lindsay@childrenscolorado.org · 720-777-8314
Children's National Medical Center, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Eugene M Hwang, MD) · ehwang@childrensnational.org · 2024765046
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Ashley Plant, MD) · Aplant@luriechildrens.org · 3122274090
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Susan C Chi, MD) · Susan_chi@dfci.harvard.edu · 6176324386
C.S. Mott Children's Hospital, Ann Arbor, Michigan, United States
Contact: Study coordinator (Santhosh Upadhyaya, MD) · saupadhy@med.umich.edu · 866-909-4449
Duke University Health System, Durham, North Carolina, United States
Contact: Study coordinator (Daniel Landi, MD) · daniel.landi@duke.edu · 19196813824
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Contact: Study coordinator (Peter M de Blank, MD) · Peter.deBlank@cchmc.org · 5135172068
Nationwide Children's Hospital, Columbus, Ohio, United States
Contact: Study coordinator (Maryam Fouladi) · Maryam.fouladi@nationwidechildrens.org · 6147225758
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Michael J Fisher, MD) · fisherm@email.chop.edu · 12155905188
Texas Children's Hospital, Houston, Texas, United States
Contact: Study coordinator (Patricia Baxter, MD) · pabaxter@txch.org · 8328244681
Seattle Children's Hospital, Seattle, Washington, United States
Contact: Study coordinator (Erin Crotty, MD) · erin.crotty@seattlechildrens.org · 206-987-2106
Sydney Children's Hospital, Randwick, New South Wales, Australia
Contact: Study coordinator (David Ziegler, MBBS) · d.ziegler@unsw.edu.au · +61293821730
Queensland Children's Hospital, South Brisbane, Queensland, Australia
Contact: Study coordinator (Tim Hassall, MBBS) · tim.hassall@health.qld.gov.au · +61730683593
Royal Children's Hospital, Melbourne, Victoria, Australia
Contact: Study coordinator (David Eisenstat, MD MA FRCPC FRACP) · David.Eisenstat@rch.org.au · +61 3 9345 5479
Perth Children's Hospital, Perth, Western Australia, Australia
Contact: Study coordinator (Nick Gottardo, MBChB, FRACP, PhD) · nick.gottardo@health.wa.gov.au · +61864560241
The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada
Contact: Study coordinator (Eric Bouffet, MD) · eric.bouffet@sickkids.ca · 4168137457
Montreal Children's Hospital, Montreal, Quebec, Canada
Contact: Study coordinator (Genevieve Legault, MD) · Genevieve.legault4@mcgill.ca · 5144124400
Hopp Children's Cancer Center at NCT Heidelberg (KiTZ), Heidelberg, Baden-Wurttemberg, Germany
Contact: Study coordinator (Olaf Witt, MD) · o.witt@kitz-heidelberg.de · 0496221423570
Princess Máxima Center, Utrecht, Netherlands
Contact: Study coordinator (Jasper van der Lugt, MD, PhD) · J.vanderLugt@prinsesmaximacentrum.nl · 31 6 18559694
Starship Children's Hospital, Auckland, Grafton, New Zealand
Contact: Study coordinator (Sarah Hunter, MB ChB) · SHunter@adhb.govt.nz · +64 9 367 0000
Great Ormond Street Hospital, London, United Kingdom
Contact: Study coordinator (Darren Hargrave, MD) · darren.hargrave@nhs.net · 02078138525

Study leads

Maryam Fouladi, MD
Study Chair
Nationwide Children's Hospital
Margot Lazow, MD
Study Director
Nationwide Children's Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

High Grade Glioma · Diffuse Intrinsic Pontine Glioma · Anaplastic Astrocytoma

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Washington D.C., United States

Sitagliptin in Recurrent/Progressive Grade 4 Glioma

Glioma · Glioblastoma · Recurrent Glioma

Abroad (travel likely)RecruitingPHASE1

Iowa City, United States

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

Glioblastoma Multiforme of Brain · Glioma · Glioblastoma

Abroad (travel likely)RecruitingPHASE1

Tampa, United States · Chicago, United States

Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)

Glioma · Glioma, Malignant · Glioblastoma

Abroad (travel likely)Recruiting

New York, United States